CG
RIGL icon

Cutler Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Cutler Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-70
Closed -$1K – 6234
2021
Q1 		$1K Sell
70
-2,020
-97% -$80K ﹤0.01% 5339
2020
Q4 		$3K Buy
+2,090
New +$60.5K ﹤0.01% 3998
2019
Q2 		– Sell
-750
Closed -$2K – 4703
2019
Q1 		$2K Sell
750
-30
-4% -$686 ﹤0.01% 3438
2018
Q4 		$2K Hold
780
– – ﹤0.01% 3416
2018
Q3 		$1K Buy
+780
New +$23.4K ﹤0.01% 3847
2017
Q1 		– Sell
-210
Closed -$1K – 7063
2016
Q4 		$1K Sell
210
-80
-28% -$2.29K ﹤0.01% 6116
2016
Q3 		$1K Buy
+290
New +$8.31K ﹤0.01% 6243

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Cutler Group's RIGL Position: Q1 2024 in Review

Cutler Group sold out of Rigel Pharmaceuticals (RIGL) in Q1 2024, closing a stake of 120 shares — an estimated $1K sold.

Cutler Group first reported a position in RIGL in Q1 2016 and held it in 22 quarters. The position peaked at $31K in Q4 2020. 117 funds tracked by Wall St. Rank hold RIGL as of Q1 2024.

  • Cutler Group reported no remaining Rigel Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 120 Rigel Pharmaceuticals shares in Q1 2024, an estimated $1K.
  • Cutler Group first reported a position in Rigel Pharmaceuticals in Q1 2016 and held it in 22 quarters.
  • Cutler Group's Rigel Pharmaceuticals position peaked at $31K in Q4 2020.
  • 117 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.